SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-041849
Filing Date
2019-11-07
Accepted
2019-11-07 16:55:43
Documents
64
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-10q_20190930.htm 10-Q 2659019
2 EX-31.1 igms-ex311_8.htm EX-31.1 19015
3 EX-31.2 igms-ex312_6.htm EX-31.2 17510
4 EX-32.1 igms-ex321_57.htm EX-32.1 17002
  Complete submission text file 0001564590-19-041849.txt   7432594

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT igms-20190930.xml EX-101.INS 1317857
6 XBRL TAXONOMY EXTENSION SCHEMA igms-20190930.xsd EX-101.SCH 48102
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE igms-20190930_cal.xml EX-101.CAL 50856
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE igms-20190930_def.xml EX-101.DEF 220064
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE igms-20190930_lab.xml EX-101.LAB 387291
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE igms-20190930_pre.xml EX-101.PRE 329847
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 191201125
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences